PDGFRB and prostate cancer: Blockade of autocrine stimulation of tumor growth by blocking PDGFR in cell lines and xenograft models showed consistent positive results in dermatofibrosarcoma protuberans, prostate cancer, ovarian cancer and gliomas (reviewed in [26]).